ID
35866
Beschrijving
Fulvestrant +/- Akt Inhibition in Advanced Aromatase Inhibitor Resistant Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01992952
Link
https://clinicaltrials.gov/show/NCT01992952
Trefwoorden
Versies (1)
- 29-03-19 29-03-19 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
29 maart 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Estrogen Receptor Positive Breast Cancer NCT01992952
Eligibility Estrogen Receptor Positive Breast Cancer NCT01992952
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
fulvestrant | Phosphatidylinositide 3-Kinase Inhibitor | mTOR Inhibitor | AKT1 gene Inhibitor | AKT2 gene Inhibitor | AKT3 gene Inhibitor
Datatype
boolean
Alias
- UMLS CUI [1]
- C0935916
- UMLS CUI [2]
- C1519050
- UMLS CUI [3]
- C2746052
- UMLS CUI [4,1]
- C0812228
- UMLS CUI [4,2]
- C1999216
- UMLS CUI [5,1]
- C0812230
- UMLS CUI [5,2]
- C1999216
- UMLS CUI [6,1]
- C1332074
- UMLS CUI [6,2]
- C1999216
Beschrijving
Glucose metabolism abnormal
Datatype
boolean
Alias
- UMLS CUI [1]
- C1142273
Beschrijving
Disease Visceral Rapidly progressive | Hormone Therapy Inappropriate
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0012634
- UMLS CUI [1,2]
- C0442045
- UMLS CUI [1,3]
- C1838681
- UMLS CUI [2,1]
- C0279025
- UMLS CUI [2,2]
- C1548788
Beschrijving
Metastatic malignant neoplasm to brain | Metastatic Malignant Neoplasm to the Leptomeninges
Datatype
boolean
Alias
- UMLS CUI [1]
- C0220650
- UMLS CUI [2]
- C1704231
Beschrijving
Comorbidity Study Subject Participation Status Excluded | Heart Disease Significant
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0009488
- UMLS CUI [1,2]
- C2348568
- UMLS CUI [1,3]
- C0332196
- UMLS CUI [2,1]
- C0018799
- UMLS CUI [2,2]
- C0750502
Beschrijving
Pharmaceutical Preparations Inappropriate Combination Investigational New Drugs
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C1548788
- UMLS CUI [1,3]
- C0205195
- UMLS CUI [1,4]
- C0013230
Similar models
Eligibility Estrogen Receptor Positive Breast Cancer NCT01992952
- StudyEvent: Eligibility
C1548788 (UMLS CUI [1,2])
C0728940 (UMLS CUI [1,3])
C0679246 (UMLS CUI [2,1])
C1517927 (UMLS CUI [2,2])
C1548788 (UMLS CUI [2,3])
C0728940 (UMLS CUI [2,4])
C1334988 (UMLS CUI [2])
C0031843 (UMLS CUI [1,2])
C0232804 (UMLS CUI [2])
C0232741 (UMLS CUI [3])
C0593802 (UMLS CUI [2,1])
C0346993 (UMLS CUI [2,2])
C0593802 (UMLS CUI [2,1])
C0677850 (UMLS CUI [2,2])
C1265611 (UMLS CUI [1,2])
C0346993 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,3])
C0680854 (UMLS CUI [1,2])
C0680854 (UMLS CUI [1,2])
C0031843 (UMLS CUI [1,2])
C0678852 (UMLS CUI [2])
C0279025 (UMLS CUI [1,2])
C1519050 (UMLS CUI [2])
C2746052 (UMLS CUI [3])
C0812228 (UMLS CUI [4,1])
C1999216 (UMLS CUI [4,2])
C0812230 (UMLS CUI [5,1])
C1999216 (UMLS CUI [5,2])
C1332074 (UMLS CUI [6,1])
C1999216 (UMLS CUI [6,2])
C0442045 (UMLS CUI [1,2])
C1838681 (UMLS CUI [1,3])
C0279025 (UMLS CUI [2,1])
C1548788 (UMLS CUI [2,2])
C1704231 (UMLS CUI [2])
C2348568 (UMLS CUI [1,2])
C0332196 (UMLS CUI [1,3])
C0018799 (UMLS CUI [2,1])
C0750502 (UMLS CUI [2,2])
C1548788 (UMLS CUI [1,2])
C0205195 (UMLS CUI [1,3])
C0013230 (UMLS CUI [1,4])